ABSTRACT Background: Conflicting evidence exists on the effects of fructose consumption in people with type 1 and type 2 diabetes mellitus. No systematic review has addressed the effect of isoenergetic fructose replacement of glucose or sucrose on peak postprandial glucose, insulin, and triglyceride concentrations. Objective: The objective of this study was to review the evidence for postprandial glycemic and insulinemic responses after isoenergetic replacement of either glucose or sucrose in foods or beverages with fructose. Design: We searched the Cochrane Library, MEDLINE, EMBASE, the WHO International Clinical Trials Registry Platform Search Portal, and clinicaltrials.gov. The date of the last search was 26 April 2016. We included randomized controlled trials measuring peak postprandial glycemia after isoenergetic replacement of glucose, sucrose, or both with fructose in healthy adults or children with or without diabetes. The main outcomes analyzed were peak postprandial blood glucose, insulin, and triglyceride concentrations. Results: Replacement of either glucose or sucrose by fructose resulted in significantly lowered peak postprandial blood glucose, particularly in people with prediabetes and type 1 and type 2 diabetes. Similar results were obtained for insulin. Peak postprandial blood triglyceride concentrations did not significantly increase. Conclusions: Strong evidence exists that substituting fructose for glucose or sucrose in food or beverages lowers peak postprandial blood glucose and insulin concentrations. Isoenergetic replacement does not result in a substantial increase in blood triglyceride concentrations.
INTRODUCTION
Sugars, and particularly sugar-sweetened beverages, have recently been the focus of much attention. Of particular concern is the role of sugar consumption in obesity and the development of type 2 diabetes. The recent WHO report on sugar consumption has identified a need for systematic reviews and meta-analyses to determine the effects of intake of free sugars on diabetes-related outcomes (1) .
One current hypothesis for the progression from normoglycemia to prediabetes and ultimately diabetes states that constant exposure to high concentrations of glucose and lipids is toxic to pancreatic b cells (2) . Thus, even in normoglycemic populations, a reduction of peak postprandial glycemia should be beneficial. In prediabetic and diabetic populations, stress on pancreatic b cells from high postprandial blood glucose concentrations may exacerbate oxidative stress and accelerate the progression of the disease (3) .
Carbohydrate consumption in excess of the body's capacity for glycogen storage leads to lipogenesis. Fatty acids produced by the liver, kidneys, and adipose tissue are esterified into triglycerides and stored for later use. The primary products of such de novo lipogenesis are palmitic and stearic acids. These fatty acids have been associated with insulin resistance through their disruption of the signaling pathway for glucose transporters, which enable cells to take up and use glucose (4) . Furthermore, there is a suggestion that insulin resistance in skeletal muscle could be the result of increased intracellular fatty acid metabolites (e.g., diacylglycerol), which, in association with long-chain fatty acyl-coenzyme A, leads to a failure of phosphoinositide 3-kinase (PI-3k) activation and thus the downregulation of glucose transporters (3) . Because fructose has been associated with increased de novo lipogenesis (5, 6) , it has been suggested that fructose replacement for glucose or sucrose would raise the postprandial triglyceride concentration above that seen with glucose or sucrose, thus worsening or even causing diabetes.
We could not identify any prior systematic review that examined acute postprandial glycemia, insulinemia, and adverse events after isoenergetic fructose replacement for glucose or sucrose, which prompted us to investigate. In this article, we present the findings of a systematic review and meta-analysis of replacing glucose or sucrose with fructose in people with and without diabetes as well as in lean, overweight, and obese populations.
METHODS Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed and a checklist was completed and provided (7) .
Registration of protocol
The protocol for this meta-analysis was designed a priori and the review was registered with the PROSPERO International Prospective Register of Systematic Reviews (8) .
Data sources and searches
We searched the Cochrane Library, MEDLINE, EMBASE, the WHO International Clinical Trials Registry Platform Search Portal, and clinicaltrials.gov databases with no time or language restrictions. The date of the last search was 26 April 2016. The search strategy was designed for Entrez-PubMed by RAE, JHC, KEM, and Fiona Lithander (University of Canberra) and was converted by scientific librarians for other database searches. The Entrez-PubMed search strategy is presented in Supplemental Table 1 . The search strategy was designed to identify controlled trials involving fructose, as well as glucose or sucrose along with a marker of diabetes or glycemia and insulinemia. All citations were uploaded into EPPI-Reviewer 4 (9). After removal of duplicates, 2075 abstracts remained. These 2075 abstracts were assigned in EPPI-Reviewer 4 to 2 authors (RAE and KEM) for blinded inclusion or exclusion (k = 0.850). Differences in allocation were resolved by consensus.
Study selection
We examined the full-text articles from all included abstracts. Blinded inclusion or exclusion of full-text articles was carried out independently in EPPI-Reviewer 4 by 2 authors (RAE and KEM; k = 0.375) based on the following 6 criteria: 1) the intervention was fructose; 2) the control was either glucose or sucrose; 3) the replacement was isoenergetic (equal number of grams of sugar in each arm); 4) the study was a randomized controlled trial; 5) the study period was $45 min postprandial; and 6) the study presented data on peak postprandial blood glucose. Discrepancies between authors were resolved by consensus. Hand searching of citations was done by 1 author (RAE), and new abstracts were examined by 2 authors (RAE and KEM), as described above. To avoid double counting, for studies that had .1 fructose intervention, the lowest-dose intervention was extracted. For studies that had food as well as beverage interventions, the food interventions were extracted. The final number of included study arms was 81 from 47 individual trials ( Figure 1) . Detailed descriptions of the studies are given in Supplemental Table 2 .
Data from the included trials were extracted by one author (RAE) and double-checked by a second author (KEM). Outcome measures were extracted: peak and AUC postprandial blood glucose, peak and AUC blood insulin, peak and AUC blood triglycerides, HDL, LDL, total cholesterol, as well as participant characteristics, sample size, inclusion and exclusion criteria, and duration of intervention.
The definitions of normoglycemic, impaired glucose tolerance, and type 2 diabetes were taken from Diabetes Management in General Practice (10) . If stated, we used the study author's classification of their study population. If this was not stated, fasting blood glucose values were calculated with the use of the mean blood glucose value at time 0 of the intervention.
The study quality was assessed by following the Cochrane Handbook for Systematic Reviews (11) . Two investigators (RAE and Fiona Lithander) independently assessed the risk of bias based on 1) random sequence generation, 2) allocation concealment, 3) blinding of participants and personnel, 4) blinding of outcome assessment, 5) incomplete outcome data (attrition bias), and 6) selective reporting (reporting bias) and other bias. Studies for acute outcomes were not excluded for lack of blinding of participants or personnel, because this should not influence objective measures such as postprandial glycemia.
Data synthesis and analysis
For all outcomes, the means, along with their SEs or SDs, were extracted. Where a study had a number of arms that used the same population, we extracted data from a single arm. To avoid double counting of studies that used both sucrose and glucose as controls, the data were separated in the analyses by type of sugar. SDs were converted to SEs by using the calculation SD = SE 3 square root of the number of subjects. In the rare cases that SDs or SEs were not given and could not be calculated from other information, they were imputed by taking the mean of the SDs from all other studies of the same design that reported that outcome (12) . Of the 47 studies included, SDs were imputed for 7 studies. Outcome data were extracted into a Microsoft Excel worksheet by one author (RAE) and were double-checked by another author (KEM). For crossover studies, the difference was calculated as studies were considered to be insufficient to enable a meaningful interpretation of outcomes (12) . Heterogeneity of 0-40% as measured by I 2 was defined as unimportant, 30-60% was considered moderate heterogeneity, 50-90% was defined as substantial heterogeneity, and 85-100% was defined as considerable heterogeneity.
Sensitivity analyses were undertaken to determine the effect of diabetes status, body weight, and sugar presentation (food compared with solution).
RESULTS

Study characteristics
A total of 47 individual studies were included in the final analysis (study characteristics are provided in Table 1 ). Most studies used a crossover model, but they varied widely in the dose of fructose used as well as in its presentation. The postprandial period varied from 45 min to 24 h. The majority of studies substituted fructose for glucose rather than for sucrose.
Quality assessment
The risk of bias was low for most outcomes, although information about randomization was almost universally missing (Supplemental Figure 1 ). We did not downrate the objective outcomes if they were not blinded to participants and personnel. This is because we currently do not have any evidence that blinding participants, personnel, or both for acute, objective outcomes (such as postprandial blood glucose, postprandial blood insulin, and postprandial blood triglycerides) leads to an improvement in outcome quality.
Meta-analysis
A total of 62 study arms substituting fructose for glucose and 19 study arms substituting fructose for sucrose that measured postprandial peak blood glucose concentrations were included in this meta-analysis. For both replacements, we undertook a subgroup analysis by diabetes status (normoglycemic, impaired glucose tolerance, type 1 diabetes, and type 2 diabetes) (Figure 2, FIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses diagram of included studies. Of 2075 individual abstracts, 1929 were excluded based on the title and abstract. The full texts of the 146 remaining articles were examined by 2 study authors (RAE and KEM). Of these 146 articles, 107 were excluded. An additional 8 studies were identified by hand-searching the references of the included trials. A total of 47 trials were included in the final analysis. Of these, 81 individual study arms were included in the meta-analyses. HTA, Health Technology Assessments.
TABLE 1
Characteristics of studies and study arms included in the meta-analysis Supplemental Figure 2) . Overall, the replacement of fructose for glucose in food or beverages resulted in a reduction in peak post- Figure  2 ). Significant reductions in peak blood glucose were seen in patients with impaired glucose tolerance (P = 0.01) and type 2 diabetes (P = 0.04) compared with normoglycemic patients. An important consideration was the overall blood glucose AUC. The 12 study arms testing glucose replacement and the 6 study arms testing sucrose replacement reported the AUC in several different ways. Therefore, we took the standardized mean difference of the glucose or sucrose arms compared with the fructose arms ( Figure 3) . Both sugar replacements resulted in highly significant reductions in the blood glucose AUC (glucose replacement: P , 0.00001; sucrose replacement: P = 0.003).
To understand the role of body weight in this variable, we undertook a subgroup analysis and included only studies of peak blood glucose in normoglycemic people with body weight as the covariate. This analysis resulted in a significant difference between healthy weight and overweight subgroups (P = 0.007) (Supplemental Figure 3) . That is, within the normoglycemic population, increased body weight was correlated with a greater reduction in postprandial peak blood glucose.
To determine whether the effect seen in postprandial blood glucose would translate to a similar effect in postprandial blood insulin, we undertook a second subgroup meta-analysis. The 53 glucose replacement studies measuring peak postprandial insulin concentrations were analyzed as described above ( Figure  4, Supplemental Figure 4) . Again, the majority of studies (46 of 53 studies) were performed in normoglycemic populations. The results of replacing fructose for glucose in normoglycemic populations showed a clear reduction in peak postprandial insulin of 245.15 IU/mL (95% CI: 252.76, 237.53 IU/mL). However, the 2 studies in populations with impaired glucose tolerance experienced an even greater reduction in postprandial insulin [260.13 IU/mL (95% CI: 272.64, 247.62 IU/mL)]. This was significantly greater than that observed in normoglycemic people (P = 0.04). People with type 2 diabetes experienced a significant but small difference between post fructose and post glucose interventions. Very similar results were seen in the sucrose replacement studies (Supplemental Figure 4) . The 2 studies in people with impaired glucose tolerance demonstrated significantly lower postprandial peak blood insulin concentrations than those in normoglycemic populations (P = 0.002).
To understand the role of body weight in postprandial insulin responses, we undertook an analysis of postprandial peak blood insulin in normoglycemic subjects by body weight (Supplemental Figure 5 ). For normoglycemic populations, there was no ACUTE FRUCTOSE REPLACEMENT significant difference between healthy weight and overweight populations (P = 0.76), but obesity was significantly correlated with a greater reduction in postprandial peak blood insulin (P = 0.03). That is, for the normoglycemic population, obesity was correlated with a greater reduction in peak postprandial insulin responses.
FIGURE 2
Subgroup meta-analysis of peak postprandial blood glucose concentrations after replacement of glucose by fructose in food or beverages by diabetes status. Data are presented as the mean differences (95% CIs) (expressed as mmol/L) between peak postprandial blood glucose after fructose consumption and peak postprandial blood glucose after glucose consumption. Data are grouped according to diabetes status at the start of the study, as defined by Diabetes Management in General Practice (10) . Numbers in parentheses next to the study name indicate the reference number. IV, inverse variance.
For both blood glucose and blood insulin outcomes, there was high heterogeneity present. We suspected that this heterogeneity was due to large variations in the dose of sugar used as well other differences in the populations (such as diabetes status or body weight). To test this hypothesis, we undertook a meta-regression of postprandial blood glucose concentrations in all acute studies ( Table 2 ). The covariates included were dose, diabetes status, and body weight. The meta-regression demonstrated highly significant correlations (P , 0.001) for dose and type 2 diabetes and a significant correlation with being overweight (P = 0.016).
As discussed in the introduction, fructose consumption has been repeatedly associated with raised blood triglyceride concentrations. In 10 of our acute studies, postprandial blood triglyceride concentrations were measured after replacing fructose for glucose (6, 19, 21, 29, 36, 39, 43, 44, 54, 55, 61, 62) or sucrose (6, 19, 29, 36 ) ( Figure 5 ). Neither replacement of fructose for glucose nor sucrose resulted in a significant increase in postprandial peak blood triglycerides (glucose: P = 0.15; sucrose: P = 0.42).
We were concerned that the manner of presentation of the fructose, glucose, or sucrose could confound the results. Therefore, we did a subgroup analysis of studies in normoglycemic, healthy weight populations by presentation of the test sugar ( Figure 6) . We divided the studies into solutions (e.g., 50 g glucose dissolved in water with lemon flavoring) compared with food (e.g., a meal with a glucose drink, or a glucose drink with fat, protein, or fat and protein added). There were no significant differences between these subgroups in peak postprandial blood glucose (P = 0.09).
To test for publication bias, we compiled funnel plots (Supplemental Figure 6 ) and subjected them to Egger's test for funnel plot asymmetry. Plots measuring blood glucose (Supplemental Figure 6A ) and blood insulin (Supplemental Figure 6B ) are likely to be asymmetrical (P = 0.002, P , 0.0001, respectively), whereas the plot of studies measuring blood triglycerides (Supplemental Figure 6C ) is symmetrical according to this test (P = 0.754).
A summary of all results can be found in Supplemental Table 3 .
DISCUSSION
A recent summit of experts recognized the importance of postprandial glycemia for health (63) . Raised postprandial glycemia is linked to all-cause mortality, an increased risk of diabetes, cardiovascular events, and weight gain even in healthy populations (64, 65) . Because every person with type 2 diabetes once had normal glucose tolerance, it is important to investigate the role of postprandial glycemia and insulinemia in the transition from normoglycemia to impaired glucose tolerance and then to type 2 diabetes mellitus. Although the exact mechanism of progression to type 2 diabetes mellitus has not been established, decreasing b cell function, perhaps through glucolipotoxicity (2), oxidative stress (66), or other mechanisms (67, 68) , is a consequence that may be reversible through dietary and exercise interventions (66, 69, 70) .
The finding that postprandial peak blood glucose concentrations were lowered (Figure 2, Supplemental Figure 2 ) in those consuming fructose was not unexpected. Fructose must first be converted to glucose to influence blood glucose concentrations, and thus, by definition, does not raise blood glucose as quickly as sucrose or glucose. Importantly, however, we found that peak blood glucose reductions are more pronounced in individuals with impaired glucose tolerance or type 1 or type 2 diabetes. This reinforces the potential benefits for glycemic control from the isoenergetic exchange of glucose or sucrose in food or beverages with fructose. Because blood glucose control is strongly associated with increased quality of life (71) , this benefit alone may justify the replacement of glucose or sucrose by fructose.
We found that body weight was correlated with reduced postprandial blood glucose (Supplemental Figure 3) . Overweight individuals were more likely to have a greater reduction in postprandial peak blood glucose than those of healthy body weight, independent of diabetes status. This finding demonstrates the applicability of both weight reduction approaches and replacement of fructose for glucose or sucrose in overweight and obese populations. Another expected finding was that fructose exchange for sucrose or glucose significantly lowered peak postprandial blood insulin concentrations (Figure 4 ). The ingestion of fructose does not immediately result in the release of insulin. Instead, it is metabolized in the liver, and thus does not stimulate the same degree of insulin release (51). However, as for peak blood glucose, the important finding is that those with impaired glucose tolerance experienced the greatest reduction in peak postprandial blood insulin concentrations. This in turn reduced the load on the pancreatic b cells, which may have long-term benefits for glucose control. People with type 2 diabetes, who have passed through glucoadaptation of the pancreatic b cells into b cell FIGURE 4 Subgroup meta-analysis of peak postprandial blood insulin concentrations after replacement of glucose by fructose in food or beverages by diabetes status. Data are presented as the mean difference (95% CIs) (expressed as IU/mL) between peak postprandial blood insulin after fructose consumption and peak postprandial blood insulin after glucose consumption. Data are grouped according to diabetes status at the start of the study, as defined by Diabetes Management in General Practice (10) . Numbers in parentheses next to the study name indicate the reference number. IV, inverse variance. dysfunction (2), showed the lowest postprandial peak insulin concentrations.
Another analysis by body weight (Supplemental Figure 5 ) showed a greater reduction in postprandial peak insulin in normoglycemic, obese populations, and this was significantly different from insulin concentrations in normal-weight populations.
A great deal of research into fructose consumption focuses on blood triglycerides. Excess dietary carbohydrates can be stored for later use as glycogen via glycogenesis and fatty acids via de novo lipogenesis. The conversion of carbohydrates into triglycerides has been studied mainly in animal models. However, the use of rats and mice for extrapolation is often problematic. Major metabolic differences exist between humans and rodents (72, 73) , not least in de novo lipogenesis. Indeed, as demonstrated by Letexier et al. (74) , de novo lipogenesis in rats is far greater than that seen in humans. Nevertheless, several studies reported that fructose consumption raised blood triglycerides (5, 44, 54) . In contrast, a 2008 meta-analysis found fructose doses of ,50 g had no significant effect on postprandial triglycerides, with doses from 50-100 g having no significant effect when subjects were fasting (75) . Our article provides additional evidence that fructose consumption has no significant effect on blood triglycerides.
A major flaw with many earlier studies in this area is the use of unsuitable controls or the lack of controls. Because all carbohydrates, not just fructose, can be converted into fatty acids, it is vital that any study that wishes to ascribe observed changes in triglyceride concentrations to different carbohydrate sources should do so only with an isoenergetic control. In fact, the failure to account for excess energy in many studies means that causation cannot reliably be applied. Thus, our meta-analysis included only studies that substituted fructose for glucose or sucrose isoenergetically. Our findings demonstrate that peak postprandial 
Subgroup meta-analysis of peak postprandial blood triglyceride concentrations after replacement of glucose or sucrose in food or beverages by substituted sugar. Data are presented as the mean differences (95% CIs) (expressed as mmol/L) between the peak postprandial blood triglycerides after fructose consumption and peak postprandial blood triglycerides after glucose or sucrose consumption. Numbers in parentheses next to the study name indicate the reference number. IV, inverse variance. blood triglyceride concentrations were not raised significantly after fructose consumption ( Figure 5 ). This is in concordance with a systematic review and meta-analysis examining postprandial blood triglycerides (but not glucose or insulin) (76) , in which isoenergetic exchange of fructose for other carbohydrates did not lead to an increase in postprandial blood triglycerides. Thus, a possible trade-off between reduced glycemia and increased triglycerides may not be necessary. In any case, the role of triglycerides as a cause, and not just a marker, of disease has not been fully established (77) .
The results of our systematic review and meta-analysis on isoenergetic exchange of glucose or sucrose by fructose suggest that there are benefits to fructose consumption without concomitant adverse effects on blood lipids. Given the current level of interest in dietary fructose, we feel that this meta-analysis is timely. Medical and health practitioners who are unsure about recommending sugar replacement to patients with or at risk of diabetes should feel assured that the benefits of reducing postprandial peak blood glucose and insulin do not come at the expense of raised blood lipid concentrations. Replacement of fructose for glucose or sucrose could be achieved in the diet by replacing sucrose or glucose with fructose in recipes and choosing premade products sweetened with fructose rather than glucose or sucrose. Furthermore, given that fructose has 1.2-1.7 (78, 79) times the sweetness of sucrose, an overall reduction in sugar intake should be achievable. It should be noted, however, that for food technological or other reasons, it may not be possible to completely replace sucrose or glucose with fructose.
It is important to establish whether these short-term reductions in peak blood glucose and insulin result in long-term changes in fasting blood glucose or insulin concentrations. In our companion review (80), we completed a systematic review and meta-analysis on the isoenergetic exchange of glucose or sucrose by fructose in long-term feeding studies.
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FIGURE 6
Subgroup meta-analysis of peak postprandial blood glucose concentrations after replacement of glucose by fructose in food or beverages in healthy weight, normoglycemic populations by sugar presentation. Data are presented as the mean differences (95% CIs) (expressed as mmol/L) between the peak postprandial blood glucose after fructose consumption and peak postprandial blood glucose after glucose consumption. Data are grouped by their presentation to participants (as a solution or as a food). Numbers in parentheses next to the study name indicate the reference number. IV, inverse variance.
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